Adverse Blood Transfusion Outcomes: Establishing Causation

Transfusion Medicine Reviews

Volumn 25, Issue 2, 2011, Pages 89-101

  Isbister, James P ^a,b   Shander, Aryeh ^c   Spahn, Donat R ^d   Erhard, Jochen ^e   Farmer, Shannon L ^f   Hofmann, Axel ^g  

^a Society for the Advancement of Blood Management   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f CURTIN UNIVERSITY   (Australia)

^g Medical Society for Blood Management   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; ARTICLE; ASSISTED VENTILATION; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONSUMER; CYTOMEGALOVIRUS INFECTION; ENDOTOXEMIA; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION RISK; LENGTH OF STAY; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; POSTTRANSFUSION PURPURA; PRACTICE GUIDELINE; PSEUDOHEMOLYTIC TRANSFUSION REACTION; PURPURA; RISK FACTOR; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT OUTCOME; VASCULAR DISEASE;

ALGORITHMS; BLOOD TRANSFUSION; CAUSALITY; ERYTHROCYTES; EVIDENCE-BASED MEDICINE; HUMANS; RESEARCH DESIGN; RISK; RISK MANAGEMENT; SAFETY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79952707725     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2010.11.001     Document Type: Article

References (84)

1. Holzer B.R., Egger M., Teuscher T., et al. Childhood anemia in Africa: To transfuse or not transfuse?. Acta tropica 1993, 55:47-51.
2. Lackritz E.M., Campbell C.C., Ruebush T.K., et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992, 340:524-528.
3. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340:409-417.
4. Isbister J.P. Decision making in perioperative transfusion. Transfus Apheresis Sci 2002, 27:19-28.
5. Isbister J.P. Clinicians as gatekeepers: What is the best route to optimal blood use?. Dev Biol (Basel) 2007, 127:9-14.
6. Goodnough L.T., Shander A. Blood management. Arch Pathol Lab Med 2007, 131:695-701.
7. Murphy G.J., Reeves B.C., Rogers C.A., et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007, 116:2544-2552.
8. Koch C.G., Li L., Duncan A.I., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006, 34:1608-1616.
9. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562.
10. Doyle B.J., Rihal C.S., Gastineau D.A., et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: Implications for contemporary practice. J Am Coll Cardiol 2009, 53:2019-2027.
11. Khorana A.A., Francis C.W., Blumberg N., et al. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008, 168:2377-2381.
12. Bateman S.T., Lacroix J., Boven K., et al. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med 2008, 178:26-33.
13. Engoren M., Mitchell E., Perring P., et al. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture. J Trauma 2008, 65:1411-1415.
14. Surgenor S.D., DeFoe G.R., Fillinger M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006, 114(1 Suppl):I43-I48.
15. Reeves B.C., Murphy G.J. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Anaesthesiol 2008, 21:669-673.
16. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: Proven beyond a reasonable doubt. Transfusion 2005, 45(Suppl 2):33S-40S.
17. Hill G.E., Frawley W.H., Griffith K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma 2003, 54:908-914.
18. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 2008, 36:1-8.
19. Taylor R.W., O'Brien J., Trottier S.J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006, 34:2302-2308.
20. Bernard A.C., Davenport D.L., Chang P.K., et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009, 208:931-937.
21. Shander A., Spence R.K., Adams D., et al. Timing and incidence of postoperative infections associated with blood transfusion: Analysis of 1,489 orthopedic and cardiac surgery patients. Surg Infect 2009, 10:277-283.
22. Chaiwat O., Lang J.D., Vavilala M.S., et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology 2009, 110:351-360.
23. Croce M.A., Tolley E.A., Claridge J.A., et al. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005, 59:19-23.
24. Spiess B.D. Risks of transfusion: Outcome focus. Transfusion 2004, 44(12 Suppl):4S-14S.
25. Nowak R. Blood doesn't always save lives. New Sci 2008, 8-9.
26. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
27. Malone D.L., Dunne J., Tracy J.K., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54:898-905.
28. Salim A., Hadjizacharia P., DuBose J., et al. Role of anemia in traumatic brain injury. J Am Coll Surg 2008, 207:398-406.
29. Bochicchio G.V., Napolitano L., Joshi M., et al. Outcome analysis of blood product transfusion in trauma patients: A prospective, risk-adjusted study. World J Surg 2008, 10:2185-2189.
30. Beattie W.S., Karkouti K., Wijeysundera D.N., et al. Risk associated with preoperative anemia in noncardiac surgery: A single-center cohort study. Anesthesiology 2009, 110:574-581.
31. Karkouti K., Wijeysundera D.N., Yau T.M., et al. Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation 2009, 119:495-502.
32. Rogers M.A., Blumberg N., Saint S.K., et al. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J 2006, 152:1028-1034.
33. Palmieri T.L., Caruso D.M., Foster K.N., et al. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crit Care Med 2006, 34:1602-1607.
34. Weightman W.M., Gibbs N.M., Sheminant M.R., et al. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology 2009, 111:327-333.
35. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001, 345:1230-1236.
36. Hogman C.F., Meryman H.T. Red blood cells intended for transfusion: Quality criteria revisited. Transfusion 2006, 46:137-142.
37. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
38. Weinberg J.A., McGwin G., Marques M.B., et al. Transfusions in the less severely injured: Does age of transfused blood affect outcomes?. J Trauma 2008, 65:794-798.
39. Hess J.R. Red cell storage. J Proteomics 2010, 73:368-373.
40. Tinmouth A., Fergusson D., Yee I.C., et al. Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46:2014-2027.
41. Cabrales P., Intaglietta M., Tsai A.G. Transfusion restores blood viscosity and reinstates microvascular conditions from hemorrhagic shock independent of oxygen carrying capacity. Resuscitation 2007, 75:124-134.
42. Isbister J.P. Is the clinical significance of blood storage lesions underestimated?. Trans Altern Trans Med 2003, 5:356-362.
43. Solheim B.G., Flesland O., Seghatchian J., et al. Clinical implications of red blood cell and platelet storage lesions: An overview. Transfus Apheresis Sci 2004, 31:185-189.
44. Frenzel T., Westphal-Varghese B., Westphal M. Role of storage time of red blood cells on microcirculation and tissue oxygenation in critically ill patients. Curr Opin Anaesthesiol 2009, 22:275-280.
45. Wilson K. The Krever Commission-10 years later. CMAJ 2007, 177:1387-1389.
46. Shander A., Hofmann A., Gombotz H., et al. Estimating the cost of blood: Past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007, 21:271-289.
47. Shander A., Hofmann A., Ozawa S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50:753-765.
48. Custer B. The cost of blood: Did you pay too much or did you get a good deal?. Transfusion 2010, 50:742-744.
49. Varney S.J., Guest J.F. The annual cost of blood transfusions in the UK. Transfus Med 2003, 13:205-218.
50. Turner M. Transfusion safety with regards to prions: Ethical, legal and societal considerations. Transfus Clin Biol 2006, 13:317-319.
51. Wilson K., Wilson M., Hebert P.C., et al. The application of the precautionary principle to the blood system: The Canadian blood system's vCJD donor deferral policy. Transfus Med Rev 2003, 17:89-94.
52. Morris J. The relationship between risk analysis and the precautionary principle. Toxicology 2002, 181-182:127-130.
53. Reyes G., Nuche J.M., Sarraj A., et al. Bloodless cardiac surgery in Jehovah's Witnesses: Outcomes compared with a control group. Rev Esp Cardiol 2007, 60:727-731.
54. Ott D.A., Cooley D.A. Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA 1977, 238:1256-1258.
55. Parascandola M., Weed D.L. Causation in epidemiology. J Epidemiol Community Health 2001, 55:905-912.
56. O'Brien S.J., Goedert J.J. HIV causes AIDS: Koch's postulates fulfilled. Curr Opin Immunol 1996, 8:613-618.
57. Inglis T.J. Principia aetiologica: Taking causality beyond Koch's postulates. J Med Microbiol 2007, 56(Pt 11):1419-1422.
58. Garcion E., Naveilhan P., Berger F., et al. Cancer stem cells: Beyond Koch's postulates. Cancer Lett 2009, 278:3-8.
59. Brown M.S., Goldstein J.L. Koch's postulates for cholesterol. Cell 1992, 71:187-188.
60. Oxman A.D. Checklists for review articles. BMJ 1994, 309:648-651.
61. Efron B.R.A. Fisher in the 21st century. Stat Sci 1998, 13:95-122.
62. Cochrane A.L. The detection of pulmonary tuberculosis in a community. Br Med Bull 1954, 10:91-95.
63. Doll R., Hill A.B. The mortality of doctors in relation to their smoking habits: A preliminary report. Br Med J 1954, 1:1451-1455.
64. Hill A.B. The environment and disease: Association or causation?. Proc R Soc Med 1965, 58:295-300.
65. Doll R., Hill A.B. Lung cancer and other causes of death in relation to smoking: A second report on the mortality of British doctors. Br Med J 1956, 2:1071-1081.
66. Kannerstein M., Churg J., McCaughey W.T. Asbestos and mesothelioma: A review. Pathol Annu 1978, 13(Pt 1):81-129.
67. Howick J., Glasziou P., Aronson J.K. The evolution of evidence hierarchies: What can Bradford Hill's 'guidelines for causation' contribute?. J R Soc Med 2009, 102:186-194.
68. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol 2008, 21:664-668.
69. Claridge J.A., Sawyer R.G., Schulman A.M., et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 2002, 68:566-572.
70. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): An update. Blood Rev 2007, 21:327-348.
71. Raat N.J., Ince C. Oxygenating the microcirculation: The perspective from blood transfusion and blood storage. Vox Sang 2007, 93:12-18.
72. Kim P., Dixon S., Eisenbrey A.B., et al. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol 2007, 30(10 Suppl 2):II35-II43.
73. Brand A. Immunological aspects of blood transfusions. Transpl Immunol 2002, 10:183-190.
74. Blumberg N., Heal J.M. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994, 118:371-379.
75. Vanrenterghem Y., Waer M., Roels L., et al. A prospective, randomized trial of pretransplant blood transfusions in cadaver kidney transplant candidates. Leuven Collaborative Group for Transplantation. Transpl Int 1994, 7(Suppl 1):S243-S246.
76. Higgins R.M., Raymond N.T., Krishnan N.S., et al. Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. Transplantation 2004, 77:469-471.
77. Ross W.B., Yap P.L. Blood transfusion and organ transplantation. Blood Rev 1990, 4:252-258.
78. Fergusson D.A., Hebert P.C., Mazer C.D., et al. A comparison of aprotinin and Lysine analogues in high-risk cardiac surgery. N Engl J Med 2008, 358:2319-2331.
79. Beale R. The rational use of blood. ANZ J Surg 1976, 46:309-313.
80. Blumberg N. Allogeneic transfusion and infection: Economic and clinical implications. Semin Hematol 1997, 34(3 Suppl 2):34-40.
81. Lacroix J., Hebert P.C., Hutchison J.S., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007, 356:1609-1619.
82. Jackson G.N., Snowden C.A., Indrikovs A.J. A prospective audit program to determine blood component transfusion appropriateness at a large university hospital: A 5-year experience. Transfus Med Rev 2008, 22:154-161.
83. Gombotz H., Rehak P., Shander A., et al. Blood use in elective surgery: The Austrian benchmark study. Transfusion 2007, 47:1468-1480.
84. Pape A., Habler O. Alternatives to allogeneic blood transfusions. Best Pract Res Clin Anaesthesiol 2007, 21:221-239.